Novel Tricyclic Psychedelic Psychoplastogens as 5‑HT2C Agonists for Treating Neurological Diseases

  • ACS Med Chem Lett. 2025 Jun 29;16(7):1268-1269. doi: 10.1021/acsmedchemlett.5c00381.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
PMID: 40666469 DOI: 10.1021/acsmedchemlett.5c00381
Abstract

Provided herein are novel tricyclic psychedelic psychoplastogens as 5-HT2C agonists, pharmaceutical compositions, use of such compounds in treating neurological diseases, and processes for preparing such compounds.

Products